171 related articles for article (PubMed ID: 36248188)
1. Lysophosphatidic Acid Induced Apoptosis, DNA Damage, and Oxidative Stress in Spinal Cord Neurons by Upregulating LPA4/LPA6 Receptors.
Yang Y; Xu J; Su Q; Wu Y; Li Q; Ma Z; Ding T
Mediators Inflamm; 2022; 2022():1818758. PubMed ID: 36248188
[TBL] [Abstract][Full Text] [Related]
2. Lysophosphatidic acid-induced YAP/TAZ activation promotes developmental angiogenesis by repressing Notch ligand Dll4.
Yasuda D; Kobayashi D; Akahoshi N; Ohto-Nakanishi T; Yoshioka K; Takuwa Y; Mizuno S; Takahashi S; Ishii S
J Clin Invest; 2019 Jul; 129(10):4332-4349. PubMed ID: 31335323
[TBL] [Abstract][Full Text] [Related]
3. Lysophosphatidic acid (LPA) signaling via LPA
Takahashi K; Fukushima K; Onishi Y; Inui K; Node Y; Fukushima N; Honoki K; Tsujiuchi T
Biochem Biophys Res Commun; 2017 Jan; 483(1):652-657. PubMed ID: 27993681
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanism of lysophosphatidic acid-induced hypertensive response.
Kano K; Matsumoto H; Inoue A; Yukiura H; Kanai M; Chun J; Ishii S; Shimizu T; Aoki J
Sci Rep; 2019 Feb; 9(1):2662. PubMed ID: 30804442
[TBL] [Abstract][Full Text] [Related]
5. P2Y5 is a G(alpha)i, G(alpha)12/13 G protein-coupled receptor activated by lysophosphatidic acid that reduces intestinal cell adhesion.
Lee M; Choi S; Halldén G; Yo SJ; Schichnes D; Aponte GW
Am J Physiol Gastrointest Liver Physiol; 2009 Oct; 297(4):G641-54. PubMed ID: 19679818
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of a novel lysophosphatidic acid receptor, p2y5/LPA6.
Yanagida K; Masago K; Nakanishi H; Kihara Y; Hamano F; Tajima Y; Taguchi R; Shimizu T; Ishii S
J Biol Chem; 2009 Jun; 284(26):17731-41. PubMed ID: 19386608
[TBL] [Abstract][Full Text] [Related]
7. LPA(4)/GPR23 is a lysophosphatidic acid (LPA) receptor utilizing G(s)-, G(q)/G(i)-mediated calcium signaling and G(12/13)-mediated Rho activation.
Lee CW; Rivera R; Dubin AE; Chun J
J Biol Chem; 2007 Feb; 282(7):4310-4317. PubMed ID: 17166850
[TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidic acid receptor type 2 activation contributes to secondary damage after spinal cord injury in mice.
López-Serrano C; Santos-Nogueira E; Francos-Quijorna I; Coll-Miró M; Chun J; López-Vales R
Brain Behav Immun; 2019 Feb; 76():258-267. PubMed ID: 30550929
[TBL] [Abstract][Full Text] [Related]
9. Mitogenic signaling by lysophosphatidic acid (LPA) involves Galpha12.
Radhika V; Hee Ha J; Jayaraman M; Tsim ST; Dhanasekaran N
Oncogene; 2005 Jun; 24(28):4597-603. PubMed ID: 15856019
[TBL] [Abstract][Full Text] [Related]
10. Diverse effects of LPA4, LPA5 and LPA6 on the activation of tumor progression in pancreatic cancer cells.
Ishii S; Hirane M; Fukushima K; Tomimatsu A; Fukushima N; Tsujiuchi T
Biochem Biophys Res Commun; 2015 May; 461(1):59-64. PubMed ID: 25849892
[TBL] [Abstract][Full Text] [Related]
11. The G-protein G13 but not G12 mediates signaling from lysophosphatidic acid receptor via epidermal growth factor receptor to Rho.
Gohla A; Harhammer R; Schultz G
J Biol Chem; 1998 Feb; 273(8):4653-9. PubMed ID: 9468525
[TBL] [Abstract][Full Text] [Related]
12. Activation of Lysophosphatidic Acid Receptor Type 1 Contributes to Pathophysiology of Spinal Cord Injury.
Santos-Nogueira E; López-Serrano C; Hernández J; Lago N; Astudillo AM; Balsinde J; Estivill-Torrús G; de Fonseca FR; Chun J; López-Vales R
J Neurosci; 2015 Jul; 35(28):10224-35. PubMed ID: 26180199
[TBL] [Abstract][Full Text] [Related]
13. Activation of RhoA by lysophosphatidic acid and Galpha12/13 subunits in neuronal cells: induction of neurite retraction.
Kranenburg O; Poland M; van Horck FP; Drechsel D; Hall A; Moolenaar WH
Mol Biol Cell; 1999 Jun; 10(6):1851-7. PubMed ID: 10359601
[TBL] [Abstract][Full Text] [Related]
14. Glycogen synthase kinase-3 is activated in neuronal cells by Galpha12 and Galpha13 by Rho-independent and Rho-dependent mechanisms.
Sayas CL; Avila J; Wandosell F
J Neurosci; 2002 Aug; 22(16):6863-75. PubMed ID: 12177184
[TBL] [Abstract][Full Text] [Related]
15. LPA4/p2y9/GPR23 mediates rho-dependent morphological changes in a rat neuronal cell line.
Yanagida K; Ishii S; Hamano F; Noguchi K; Shimizu T
J Biol Chem; 2007 Feb; 282(8):5814-24. PubMed ID: 17172642
[TBL] [Abstract][Full Text] [Related]
16. The gep proto-oncogene Gα13 mediates lysophosphatidic acid-mediated migration of pancreatic cancer cells.
Gardner JA; Ha JH; Jayaraman M; Dhanasekaran DN
Pancreas; 2013 Jul; 42(5):819-28. PubMed ID: 23508014
[TBL] [Abstract][Full Text] [Related]
17. Rho/ROCK pathway is essential to the expansion, differentiation, and morphological rearrangements of human neural stem/progenitor cells induced by lysophosphatidic acid.
Frisca F; Crombie DE; Dottori M; Goldshmit Y; Pébay A
J Lipid Res; 2013 May; 54(5):1192-206. PubMed ID: 23463731
[TBL] [Abstract][Full Text] [Related]
18. Lysophosphatidic acid receptor 4 signaling potentially modulates malignant behavior in human head and neck squamous cell carcinoma cells.
Matayoshi S; Chiba S; Lin Y; Arakaki K; Matsumoto H; Nakanishi T; Suzuki M; Kato S
Int J Oncol; 2013 May; 42(5):1560-8. PubMed ID: 23467751
[TBL] [Abstract][Full Text] [Related]
19. Lysophosphatidic acid receptor, LPA
Masago K; Kihara Y; Yanagida K; Hamano F; Nakagawa S; Niwa M; Shimizu T
Biochem Biophys Res Commun; 2018 Jul; 501(4):1048-1054. PubMed ID: 29778535
[TBL] [Abstract][Full Text] [Related]
20. High Expression of Lysophosphatidic Acid Induces Nerve Injury in LSS Patients via AKT Mediated NF-κB p65 Pathway.
Zhai G; Liang W; Xu Y
Front Pharmacol; 2021; 12():641435. PubMed ID: 33815123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
